Welcome to LookChem.com Sign In|Join Free
  • or
6-azidohexyl (3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->3)-(4-O-acetyl-2,6-di-O-benzyl-β-D-galactopyranosyl)-(1->4)-2,3,6-tri-O-benzyl-β-D-glucopyranoside is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

652149-29-6

Post Buying Request

652149-29-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

652149-29-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 652149-29-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,2,1,4 and 9 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 652149-29:
(8*6)+(7*5)+(6*2)+(5*1)+(4*4)+(3*9)+(2*2)+(1*9)=156
156 % 10 = 6
So 652149-29-6 is a valid CAS Registry Number.

652149-29-6Downstream Products

652149-29-6Relevant academic research and scientific papers

Chemo-enzymatic synthesis of tetra-, penta-, and hexasaccharide fragments of the capsular polysaccharide of Streptococcus pneumoniae type 14

Joosten, John A.F.,Lazet, Bart J.,Kamerling, Johannis P.,Vliegenthart, Johannes F.G.

, p. 2629 - 2651 (2007/10/03)

The chemo-enzymatic synthesis is described of β-D-Glcp-(1→6)- [β-D-Galp-(1→4)]-β-D-GlcpNAc-(1→3)-β-D-Galp- (1→O(CH2)6NH2 (1), β-D-Glcp- (1→6)-[β-D-Galp-(1→4)]-β-D-GlcpNAc-(1→3) -β-D-Galp-(1→4)-β-D-Glcp-(1→O(CH2) 6NH2 (2), β-D-Galp-(1→4)-β-D-GlcpNAc- (1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1→O(CH2) 6NH2 (3), and β-D-Galp-(1→4)-β-D-GlcpNAc- (1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1→6)-[β-D-Galp- (1→4)]-β-D-GlcpNAc-(1→O(CH2)6NH 2 (4), representing fragments of the repeating unit of the Streptococcus pneumoniae serotype 14 capsular polysaccharide. Linear intermediate oligosaccharides 5-8 were synthesized via chemical synthesis, followed by enzymatic galactosylation using bovine milk β-1,4- galactosyltransferase as a catalyst. The title oligosaccharides form suitable compounds for conjugation with carrier proteins, to be tested as potential vaccines in animal models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 652149-29-6